The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Biological Therapy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Biological Therapy


High impact information on Biological Therapy


Chemical compound and disease context of Biological Therapy


Biological context of Biological Therapy


Anatomical context of Biological Therapy


Associations of Biological Therapy with chemical compounds


Gene context of Biological Therapy


Analytical, diagnostic and therapeutic context of Biological Therapy


  1. Recombinant interleukin 10 for the treatment of active Crohn's disease: lessons in biologic therapy. Bickston, S.J., Cominelli, F. Gastroenterology (2000) [Pubmed]
  2. Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype. Gruys, M.E., Back, T.C., Subleski, J., Wiltrout, T.A., Lee, J.K., Schmidt, L., Watanabe, M., Stanyon, R., Ward, J.M., Wigginton, J.M., Wiltrout, R.H. Cancer Res. (2001) [Pubmed]
  3. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Madhusudan, S., Foster, M., Muthuramalingam, S.R., Braybrooke, J.P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D.C., Ganesan, T.S., Harris, A.L. Clin. Cancer Res. (2004) [Pubmed]
  4. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. Yocum, D.E. Semin. Arthritis Rheum. (1999) [Pubmed]
  5. The future of biologics in the treatment of rheumatoid arthritis. Koopman, W.J. Semin. Arthritis Rheum. (1994) [Pubmed]
  6. Biologic therapy for rheumatoid arthritis. Klippel, J.H. N. Engl. J. Med. (2000) [Pubmed]
  7. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Giannelli, G., Bergamini, C., Fransvea, E., Sgarra, C., Antonaci, S. Gastroenterology (2005) [Pubmed]
  8. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Chamian, F., Lowes, M.A., Lin, S.L., Lee, E., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Cardinale, I., Khatcherian, A., Novitskaya, I., Wittkowski, K.M., Krueger, J.G. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  9. Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man. Slovin, S.F., Ragupathi, G., Adluri, S., Ungers, G., Terry, K., Kim, S., Spassova, M., Bornmann, W.G., Fazzari, M., Dantis, L., Olkiewicz, K., Lloyd, K.O., Livingston, P.O., Danishefsky, S.J., Scher, H.I. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  10. The implications of biologic therapy in ankylosing spondylitis: comment on the articles by Brandt et al and Braun et al. Mascarenhas, R., Davis, M., Robertson, L. Arthritis Rheum. (2004) [Pubmed]
  11. Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer. Sanda, M.G., Smith, D.C., Charles, L.G., Hwang, C., Pienta, K.J., Schlom, J., Milenic, D., Panicali, D., Montie, J.E. Urology (1999) [Pubmed]
  12. Protracted intravenous infusion of 5-fluorouracil in combination treatments. A review. Hansen, R.M. Acta oncologica (Stockholm, Sweden) (1991) [Pubmed]
  13. Apoptosis and a re-investigation of the biologic basis for cancer therapy. D'Amico, A.V., McKenna, W.G. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. (1994) [Pubmed]
  14. Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms. Stroncek, D.F., Basil, C., Nagorsen, D., Deola, S., Aricó, E., Smith, K., Wang, E., Marincola, F.M., Panelli, M.C. Journal of translational medicine [electronic resource]. (2005) [Pubmed]
  15. Prostate cancer, biological therapy, signal transduction inhibitors and anti-angiogenesis agents. McKinnon, C. IDrugs : the investigational drugs journal. (1999) [Pubmed]
  16. Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2. Vourka-Karussis, U., Levi-Schaffer, F., Slavin, S. Exp. Hematol. (1993) [Pubmed]
  17. Role of interleukin-2 activated MHC-nonrestricted lymphocytes in antileukemia activity and therapy. Lotzová, E. Leuk. Lymphoma (1992) [Pubmed]
  18. Safety issues related to emerging therapies for rheumatoid arthritis. Keystone, E.C. Clinical and experimental rheumatology. (2004) [Pubmed]
  19. Biological therapy for the inner ear. Patel, N.P., Mhatre, A.N., Lalwani, A.K. Expert opinion on biological therapy. (2004) [Pubmed]
  20. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway. Feldkamp, M.M., Angelov, L., Guha, A. Surgical neurology. (1999) [Pubmed]
  21. The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden. Kristensen, L.E., Saxne, T., Geborek, P. Arthritis Rheum. (2006) [Pubmed]
  22. Parenteral methotrexate should be given before biological therapy. Griffin, A.J., Erkeller-Yuksel, F. Rheumatology (Oxford, England) (2004) [Pubmed]
  23. Overview of chemotherapy for small cell lung cancer. Bunn, P.A., Carney, D.N. Semin. Oncol. (1997) [Pubmed]
  24. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. Maradit-Kremers, H., Nicola, P.J., Crowson, C.S., O'Fallon, W.M., Gabriel, S.E. J. Rheumatol. (2006) [Pubmed]
  25. Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. du Manoir, J.M., Francia, G., Man, S., Mossoba, M., Medin, J.A., Viloria-Petit, A., Hicklin, D.J., Emmenegger, U., Kerbel, R.S. Clin. Cancer Res. (2006) [Pubmed]
  26. Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor. Pegram, M.D., Reese, D.M. Semin. Oncol. (2002) [Pubmed]
  27. New directions for biological therapy in rheumatoid arthritis. Elliott, M.J., Maini, R.N. Int. Arch. Allergy Immunol. (1994) [Pubmed]
  28. Recent advances in breast cancer (the 37th ASCO meeting, May 2001). Mokbel, K., Elkak, A. Current medical research and opinion. (2001) [Pubmed]
  29. The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview. Toussirot, E., Wendling, D. Expert opinion on pharmacotherapy. (2004) [Pubmed]
  30. The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma. Figlin, R.A., Abi-Aad, A.S., Belldegrun, A., deKernion, J.B. Semin. Oncol. (1991) [Pubmed]
  31. Malignant melanoma: cost and reimbursement issues. Creagan, E.T. Semin. Oncol. (1989) [Pubmed]
  32. Biological therapies for breast carcinoma: concepts for improvement in survival. Borden, E.C., Esserman, L., Linder, D.J., Campbell, M.J., Fulton, A.M. Semin. Oncol. (1999) [Pubmed]
  33. Early diagnosis of ALS/MND. Swash, M. J. Neurol. Sci. (1998) [Pubmed]
  34. Developments in combination chemotherapy for colorectal cancer. Goetz, M.P., Grothey, A. Expert review of anticancer therapy. (2004) [Pubmed]
WikiGenes - Universities